Velarion Records
Free. Unsubscribe any time.

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. filed 48 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 75 transactions and 990,556 shares. None carries the SEC's AFF10B5ONE flag; all 48 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Mineralys Therapeutics, Inc. 75

Adoption dates in Mineralys Therapeutics, Inc. 7

Results prints in Mineralys Therapeutics, Inc. 7

Trades before a print in Mineralys Therapeutics, Inc. 3

Interval to Mineralys Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Mineralys Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on January 28, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.